Howard M Proskin (Howard Proskin)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Hyaluronic Acid

Urinary Tract Infection

Top Venues

Clinical ophthalmology (Auckland, N.Z.)

Antibiotics (Basel, Switzerland)

Howard M. Proskn & Associates, Inc.

Rutgers University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Howard M. Proskn & Associates, Inc.

United States

President

Education History

Rutgers University

United States

PHD :: Statistics

Publications

George A Yendewa, John McLeod Griffiss, Wesley A Gray, Amanda Healen, Howard M Proskin, Scott A Fulton, Mary Ann O'Riordan, Charles Hoppel, Jeffrey L Blumer, Robert A Salata
Dosing Colistimethate Every 8 h Results in Higher Plasma Concentrations of Active Colistin Than Every 12-Hourly Dosing without Increase in Nephrotoxicity: A Phase 1 Pharmacokinetics Trial in Healthy Adult Volunteers. Antibiotics (Basel, Switzerland) 11 (4) (2022)
Joseph M Blondeau, Howard M Proskin, Christine M Sanfilippo, Heleen H DeCory
Characterization of Polybacterial versus Monobacterial Conjunctivitis Infections in Pediatric Subjects Across Multiple Studies and Microbiological Outcomes with Besifloxacin Ophthalmic Suspension 0.6. Clinical ophthalmology (Auckland, N.Z.) 15 (2021)
William Reindel, Gary Mosehauer, Marjorie Rah, Howard M Proskin, Robert Steffen
Clinical Performance of Samfilcon A, a Unique Silicone Hydrogel Lens, on a 7-Day Extended Wear Basis. Clinical ophthalmology (Auckland, N.Z.) 14 (2020)